Rubicon Research Limited (BOM:544578)
1,763.75
-51.55 (-2.84%)
At close: Sep 16, 2026
Rubicon Research Market Cap
Rubicon Research has a market cap or net worth of 292.45 billion as of September 16, 2026.
Market Cap
292.45B
Enterprise Value
292.22B
Revenue
19.36B
Ranking
n/a
PE Ratio
101.47
Stock Price
1,763.75
ChartMarket Cap Chart
Since October 16, 2025, Rubicon Research's market cap has increased from 103.50B to 292.45B, an increase of 182.57%. That is a compound annual growth rate of 210.11%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2026 | 292.45B | 160.75% |
| Dec 31, 2025 | 112.15B | 8.37% |
| Oct 16, 2025 | 103.50B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Dr. Reddy's Laboratories | 957.72B |
| Lupin | 939.78B |
| Abbott India | 555.53B |
| GlaxoSmithKline Pharmaceuticals | 476.73B |
| J. B. Chemicals & Pharmaceuticals | 387.31B |
| Granules India | 216.20B |
| Caplin Point Laboratories | 195.41B |
| AstraZeneca Pharma India | 167.33B |